Professional Documents
Culture Documents
Management
2-methylserotonin
GABAB µ
§
a2
5-HT3
Nociceptor
Midozalam Citalopram
GABAA 5-HT1B
Dorsal Horn Cell
Brookoff, 2000
Pain and Suffering
The Importance of Genetics
GENETICS Placebo
Effect
N
O COMT
COMT
C Emotions
I P
C A
E Cognition (vigilance)
P MORs
I
T N
I Environment
O
N 2D6
Codeine
SUFFERING
Clinical Significance
of the Basic Science of Pain
Not all pains are the same
Not all patients have the same pain sensitivities
Not all patients have the same pain relief from
opioids
Not all patients have the same side effects of
opioids
Not all opioids are the same
Not all opioid receptors are the same
Not all mu opioid receptors are the same
Pasternak, 2001
Why use opioids at all?
Chronic Pain- Treatment Options
PHYSICAL PSYCHOLOGIC PHARMACOLOGIC INTERVENTIONAL
Normal activities Hypnosis OTC medication I.A. steroids
Aquafitness Stress CAM I.A. hyaluronan
Physio Management Topical medicationsTrigger Pt Therapy
Passive Cognitive- NSAIDs / COXIBs IMS / Prolotherapy
Active Behavioural DMARDs Nerve Blocks
Stretching Family therapy Immune modulators Botox
Conditioning Psychotherapy Tricyclics / AEDs Epidurals
Weight training Mindfulness- Opioids
Based Stress Orthopedic
Splinting / Taping Local anesthetic
Reduction Neurotomy
TENS congeners
Neurectomy
TMS / TCNS Muscle relaxants
Massage Implantable
Sympathetic agents stimulators
Chiropractic NMDA blockers Implantable pain
Acupuncture CGRP blockers pumps
Dolphin
Future Pharmacotherapies
CGRP antagonist
NMDA blockers
Cannabinoids
COX inhibitors
Bradykinin antagonists
Glutamamte antagonists
Substance P and Neurokinin antagonists
Tetrodotoxin / Omega conotoxins
CCK blockers
TRPVR1 agonist
Opioids continue to be our
most potent pain reliever
Treating Chronic Pain…
Pharmacotherapy
BENEFIT RISK
Acetaminophen
Hepatotoxicity
GI bleeding / perforation
Chronic renal failure
Hypertension
20000
15000
10000
5000
0
S s As a
mia
AI
D ID V ol m
a m r vix in s
ke A M th e gk
u NS My
e As C d
Le TOH Ca Ho
E
Singh G. Am J Med 1998
Wolfe M. NEJM, 1999
If you take an NSAID > 2 mo…
Henry McQuay
10th World Congress on Pain, 2002
http://www.jr2.ox.ac.uk/bandolier/booth/painpag/nsae/nsae.html
Approximately 1900 Canadians die annually
due to NSAID-related adverse effects *
* more than the total number of deaths due to MVCs, fires and
gunshot wounds combined
COXIBs
100000
90000
80000
70000
60000
Opioid Analgesic
50000
Related ED Visits
40000
30000
20000
10000
1996 1997 1998 1999 2000 2001
New Users of Illicit Drugs
in the Past Year
Pain Meds
3,500,000 THC
3,000,000 Cocaine
Ecstacy
2,500,000
Tranquilizers
2,000,000 Heroin
1,500,000
1,000,000
500,000
0
1965 1970 1975 1980 1985 1990 1995 1999 2000
U.S. National Household Survey on Drug Abuse, 2001
Past Year Abuse or Dependence (DSM IV)
on Alcohol or Illicit Drugs by Age
25
20
15
%
10
0
3
-15
-17
-19
-21
-23
-25
-29
-34
-39
-44
-49
-54
-59
-64
5
--1
>6
14
16
18
20
22
24
26
30
35
40
45
50
55
60
12
Age
U.S. National Household Survey on Drug Abuse, 2001
Prescription Opioid Addiction
Treatment Episode Data System, TEDS
2.50
2.00
Percent of total admissions
1.50
1.00
0.50
0.00
96
97
98
99
00
01
19
19
19
19
20
20
It really comes down to a
question of balance
Appropriate Use vs Abuse:
Maintaining the Balance
The FEW who misuse prescribed opioids
should not penalize the OVERWHELMING
MAJORITY who use opioids appropriately
Treat pain sufferers + minimize drug
diversion
Assess for risk factors
Prescribe carefully
Monitor behaviours suggestive of misuse/abuse, or
addiction
Can we predict who will
misuse prescribed opioids?
Risk factors for misuse / addiction
Family history
Previous history of alcohol abuse /
addiction
Previous history of drug abuse / addiction
Serious untreated psychiatric problems
Previous criminal behaviour
High risk home environment
Opioidology 101
Optimizing opioid use for pain
When to Consider Opioid Therapy
for Chronic Pain …
Unrelieved pain
+
Decreased QoL
+
Decrease pain
Improve function
Minimize adverse effects
Opioids are not magic !
Not all pains in all patients will respond.
Winston Churchill